ATE375717T1 - Verfahren zur inhibierung der abstossung von transplantaten - Google Patents

Verfahren zur inhibierung der abstossung von transplantaten

Info

Publication number
ATE375717T1
ATE375717T1 AT00915801T AT00915801T ATE375717T1 AT E375717 T1 ATE375717 T1 AT E375717T1 AT 00915801 T AT00915801 T AT 00915801T AT 00915801 T AT00915801 T AT 00915801T AT E375717 T1 ATE375717 T1 AT E375717T1
Authority
AT
Austria
Prior art keywords
tissues
host
immune system
lymphocytes
attack
Prior art date
Application number
AT00915801T
Other languages
English (en)
Inventor
Denise L Faustman
Original Assignee
Denise L Faustman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denise L Faustman filed Critical Denise L Faustman
Application granted granted Critical
Publication of ATE375717T1 publication Critical patent/ATE375717T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Soil Working Implements (AREA)
  • Fats And Perfumes (AREA)
  • Transplanting Machines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00915801T 1999-02-18 2000-02-18 Verfahren zur inhibierung der abstossung von transplantaten ATE375717T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25233199A 1999-02-18 1999-02-18

Publications (1)

Publication Number Publication Date
ATE375717T1 true ATE375717T1 (de) 2007-11-15

Family

ID=22955579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915801T ATE375717T1 (de) 1999-02-18 2000-02-18 Verfahren zur inhibierung der abstossung von transplantaten

Country Status (6)

Country Link
EP (1) EP1154686B1 (de)
AT (1) ATE375717T1 (de)
AU (2) AU763137B2 (de)
CA (1) CA2362161A1 (de)
DE (1) DE60036788T2 (de)
WO (1) WO2000048462A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116292A2 (en) * 2005-04-27 2006-11-02 Genencor International, Inc. Methods for reducing the immunogenicity of cytokines and removal of cell surface markers
US20250147047A1 (en) 2022-02-04 2025-05-08 Vib Vzw Methods and Applications of Analyzing the Perfusate of an Ex Situ Perfused Kidney

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399123A (en) * 1980-04-01 1983-08-16 Oliver Roy F Fibrous tissue dressing or implant
JPH04501510A (ja) * 1989-07-25 1992-03-19 セル　ジェネシス，インコーポレイティド 普遍的なドナー細胞及びキメラ性哺乳類宿主のための相同性組換え
US6056952A (en) * 1995-08-30 2000-05-02 The United States Of America As Represented By The Department Of Health And Human Services Selective elimination of T cells that recognize specific preselected targets
AU2845400A (en) * 1998-12-24 2000-07-31 Phairson Medical Inc. Treatment and prevention of immune rejection reactions

Also Published As

Publication number Publication date
EP1154686A1 (de) 2001-11-21
AU3701500A (en) 2000-09-04
AU2003255031A1 (en) 2003-11-13
EP1154686A4 (de) 2003-07-02
AU763137B2 (en) 2003-07-17
DE60036788T2 (de) 2008-07-24
WO2000048462A1 (en) 2000-08-24
CA2362161A1 (en) 2000-08-24
DE60036788D1 (de) 2007-11-29
EP1154686B1 (de) 2007-10-17

Similar Documents

Publication Publication Date Title
Jaffe et al. Synthesis of basement membrane collagen by cultured human endothelial cells.
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
AU6475186A (en) Process for separating motile sperm cells in vitro, fertilization method and penetration medium for sperm cells
ATE246166T1 (de) Verfahren zur reinigung von milchsäure
ES2156875T3 (es) Procedimiento de preparacion de una cola biologica enriquecida con factores plaquetarios y aplicacion.
ATE161041T1 (de) Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten
DE59402827D1 (de) Verfahren zur gewinnung nativer, oligomerer, glykosylierter ektodomänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
AU2115200A (en) Fibres
AU3925295A (en) Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
ATE486949T1 (de) Verfahren zur herstellung von n- acetylneuraminsäure
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
DE69737460D1 (de) Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation
ATE530657T1 (de) Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
ATE375717T1 (de) Verfahren zur inhibierung der abstossung von transplantaten
WO2001049821A3 (fr) Lignees des lymphocytes t cd4 specifiques de type th1 et procede pour leur induction ex vivo
ATE51022T1 (de) Verfahren zur enzymatischen hydrolyse von d-alpha-aminosaeureamiden.
AU2534595A (en) Angiotensin ii for improving fertilization
NO922422D0 (no) Matrise med adherent bundede celler, samt fremgangsmaate ved fremstilling av virus/virusantigener
Kanoza et al. Isolation and identification of epithelial-like cells in culture by a collagenase-separation technique
AU3980595A (en) Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens
FR2848565B1 (fr) Lignee de cellules dendritiques gen2.2
DE69117521D1 (de) Verfahren zur herstellung von 2-alkansäureenantiomeren
AU6262786A (en) Growing aids virus in cell lines lacking human class ii histocompatability antigens
DK184886A (da) Fremgangsmaade til fremstilling af celleadhaesionsinhibitorer
ATE313622T1 (de) Verfahren zur züchtung von haftenden tierischen zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties